Table 3.

Descriptive analysis of facial weakness subgroups.

	Total (n=61)	Temporary weakness (n=46)	Permanent weakness (n=6)	Undetermined due to short follow up (n=9)
Division
Upper division	7 (11.4)	4 (8.7)	0	3 (33.3)
Lower division	36 (59.0)	26 (56.5)	4 (66.7)	6 (66.7)
Both divisions	18 (29.5)	16 (34.8)	2 (33.3)	0
Grade of weakness
II	31 (50.8)	23 (52.3)	0	8 (88.9)
III	15 (24.5)	14 (31.8)	1 (16.7)	0
IV	8 (13.1)	6 (13.6)	1 (16.7)	1 (11.1)
V	3 (4.9)	1 (2.3)	2 (33.3)	0
VI	2 (3.2)	0	2 (33.3)	0
Steroid therapy
No	31 (50.8)	23 (50.0)	4 (66.7)	4 (44.4)
Yes	30 (46.2)	23 (50.0)	2 (33.3)	5 (55.6)

Data are number (%)